Abstract
We show that intensification of treatment with maraviroc in patients chronically infected with HIV-1 receiving successful long-term ART was not associated with improvements in HIV related morbidity, HIV reservoir, microbial translocation, immune activation or immune exhaustion in either gut or peripheral blood. The measurement of reservoir in both gut and blood longitudinally contributes to a paucity of data in the area.
Original language | English |
---|---|
Pages (from-to) | 143-146 |
Journal | Aids Research and Human Retroviruses |
Volume | 33 |
Issue number | 2 |
Early online date | 4 Dec 2016 |
DOIs | |
Publication status | Published - 1 Feb 2017 |